709-45-5

Basic information

• Product Name: Methyl 5-(broMoMethyl)-2-fluorobenzoate
• Synonyms: Methyl 5-(broMoMethyl)-2-fluorobenzoate;5-Bromomethyl-2-fluoro-benzoic acid methyl ester;5-(bromomethyl)-2-fluoro-methylester benzoic acid
• CAS NO: 709-45-5
• Molecular Formula: C₉H₈BrFO₂
• Molecular Weight: 247.0610232
• EINECS: -0
• Mol File: 709-45-5.mol
• Article Data: 21

Chemical Properties

• Boiling Point: 304.0±37.0 °C(Predicted)
• Appearance: /
• Density: 1.534±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: Methyl 5-(broMoMethyl)-2-fluorobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 5-(broMoMethyl)-2-fluorobenzoate(709-45-5)
• EPA Substance Registry System: Methyl 5-(broMoMethyl)-2-fluorobenzoate(709-45-5)

Safety Data

• Hazardous Substances Data: 709-45-5(Hazardous Substances Data)

Usage

General Description

Methyl 5-(bromoMethyl)-2-fluorobenzoate is a chemical compound with the molecular formula C9H8BrFO2. It is a fluorinated benzene derivative containing a bromomethyl group and a methyl ester functional group. Methyl 5-(broMoMethyl)-2-fluorobenzoate is commonly used in organic synthesis and pharmaceutical research as a building block for the preparation of various fluorinated organic compounds. It may also have potential applications in the development of new drugs and agrochemicals due to its unique structural features. However, as with any chemical, it is important to handle and use Methyl 5-(bromoMethyl)-2-fluorobenzoate with appropriate safety precautions and in accordance with all relevant regulations and guidelines.

Upstream product

• 2967-93-3 2-fluoro-5-methyl benzoic acid methyl ester 
• 321-12-0 2-fluoro-5-methyl-benzoic acid 
• 64113-84-4 2-fluoro-5-methylbenzonitrile 
• 816449-70-4 methyl 2-fluoro-5-(hydroxymethyl)benzoate 
• 165803-94-1 methyl 2-fluoro-5-formylbenzoate 
• 77771-02-9 3-bromo-4-fluorobenzaldehyde 

Downstream Products

• 256345-52-5 5-[(3aS,4R,8R,8aS)-4,8-Dibenzyl-2,2-dimethyl-7-(3-nitro-benzyl)-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-2-fluoro-benzoic acid methyl ester 
• 256345-53-6 (3aS,4R,8R,8aS)-4,8-Dibenzyl-5-(3-hydroxy-1H-indazol-5-ylmethyl)-2,2-dimethyl-7-(3-nitro-benzyl)-hexahydro-1,3-dioxa-5,7-diaza-azulen-6-one 
• 256345-54-7 5-[(3aS,4R,8R,8aS)-4,8-Dibenzyl-2,2-dimethyl-7-(3-nitro-benzyl)-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-3-hydroxy-indazole-1-carboxylic acid tert-butyl ester 
• 256345-68-3 5-[(3aS,4R,8R,8aS)-7-(3-Amino-benzyl)-4,8-dibenzyl-2,2-dimethyl-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-3-thiophen-3-yl-indazole-1-carboxylic acid tert-butyl ester 
• 256345-67-2 5-[(3aS,4R,8R,8aS)-7-(3-Amino-benzyl)-4,8-dibenzyl-2,2-dimethyl-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-3-thiophen-2-yl-indazole-1-carboxylic acid tert-butyl ester 
• 256345-57-0 5-[(3aS,4R,8R,8aS)-4,8-Dibenzyl-2,2-dimethyl-7-(3-nitro-benzyl)-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-3-thiophen-2-yl-indazole-1-carboxylic acid tert-butyl ester 
• 256345-58-1 5-[(3aS,4R,8R,8aS)-4,8-Dibenzyl-2,2-dimethyl-7-(3-nitro-benzyl)-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-3-thiophen-3-yl-indazole-1-carboxylic acid tert-butyl ester 
• 256345-65-0 5-[(3aS,4R,8R,8aS)-4,8-Dibenzyl-2,2-dimethyl-7-(3-nitro-benzyl)-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-3-(4-methoxy-phenyl)-indazole-1-carboxylic acid tert-butyl ester 
• 256345-70-7 5-[(3aS,4R,8R,8aS)-7-(3-Amino-benzyl)-4,8-dibenzyl-2,2-dimethyl-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-3-(4-fluoro-phenyl)-indazole-1-carboxylic acid tert-butyl ester 
• 256345-74-1 5-[(3aS,4R,8R,8aS)-7-(3-Amino-benzyl)-4,8-dibenzyl-2,2-dimethyl-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-3-(3-methoxy-phenyl)-indazole-1-carboxylic acid tert-butyl ester 
• 256345-75-2 5-[(3aS,4R,8R,8aS)-7-(3-Amino-benzyl)-4,8-dibenzyl-2,2-dimethyl-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-3-(4-methoxy-phenyl)-indazole-1-carboxylic acid tert-butyl ester 
• 256345-64-9 5-[(3aS,4R,8R,8aS)-4,8-Dibenzyl-2,2-dimethyl-7-(3-nitro-benzyl)-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-3-(3-methoxy-phenyl)-indazole-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

Pyrrolopyrazole derivative and preparation method and medical application thereof

The invention relates to a pyrrolopyrazole derivative and a preparation method and a medical application thereof. Specifically, the invention relates to a new pyrrolopyrazole derivative as shown in ageneral formula (I), a preparation method of the pyrrolopyrazole derivative and application of the pyrrolopyrazole derivative or a pharmaceutical composition containing the pyrrolopyrazole derivativeas a therapeutic agent, particularly as a gastric acid secretion inhibitor and potassium ion competitive acid blockers (P-CABs) in biological medicines, wherein substituents (R1, R2, R3 and R4) and groups (X) in the general formula (I) are the same as defined in the specification.

MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS

Methods are provided for modulating MRGPR X4 generally, or for treating a MRGPR X4 dependent condition more specifically, by contacting the MRGPR X4 or administering to a subject in need thereof, respectively, an effective amount of a compound having the structure of Formula (I): (I) or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein n, x, A, Q1, Q2, Z, R, R1, R2, R3, R4 and R5 are as defined herein. Pharmaceutical compositions containing such compounds, as well as to compounds themselves, are also provided.

WDR5-MLL1 INHIBITORS AND MODULATORS

Benzamides and picolinamides that are meta-substituted with imino-, guanidino-, or heterocycle-containing groups disrupt the WDR5-MLL1 protein-protein interaction, and have use in pharmaceutical compositions and in treating proliferative disorders and conditions in a subject, such as cancer.